Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.

Ondřej Májek; Jakub Gregor; Nesrin Mogulkoć; Katarzyna Lewandowska; Martina Šterclová; Veronika Müller; Marta Hájková; Mordechai R Kramer; Jasna Tekavec-Trkanjec; Dragana Jovanović; Michael Studnicka; Natalia Stoeva; Klaus-Uwe Kirchgässler; Simona Littnerová; Ladislav Dušek; Martina Koziar Vašáková

doi:10.1371/journal.pone.0273854

Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.

Ondřej Májek, Jakub Gregor, Nesrin Mogulkoć, Katarzyna Lewandowska, Martina Šterclová, Veronika Müller, Marta Hájková, Mordechai R Kramer, Jasna Tekavec-Trkanjec, Dragana Jovanović, Michael Studnicka (Co-author), Natalia Stoeva, Klaus-Uwe Kirchgässler, Simona Littnerová, Ladislav Dušek, Martina Koziar Vašáková

Department of Pneumology

Research output: Contribution to journal › Original Article (Journal) › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	e0273854
Journal	PLOS ONE
Volume	17
Issue number	9
DOIs	https://doi.org/10.1371/journal.pone.0273854
Publication status	Published - 2022

Keywords

NINTEDANIB
CAPACITY

Access to Document

10.1371/journal.pone.0273854

Cite this

Májek, O., Gregor, J., Mogulkoć, N., Lewandowska, K., Šterclová, M., Müller, V., Hájková, M., Kramer, M. R., Tekavec-Trkanjec, J., Jovanović, D., Studnicka, M., Stoeva, N., Kirchgässler, K.-U., Littnerová, S., Dušek, L., & Vašáková, M. K. (2022). Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone. PLOS ONE, 17(9), e0273854. https://doi.org/10.1371/journal.pone.0273854

@article{fb8b9b1cc1434180a90cbe8951d4dc3c,

title = "Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.",

keywords = "NINTEDANIB, CAPACITY",

author = "Ond{\v r}ej M{\'a}jek and Jakub Gregor and Nesrin Mogulko{\'c} and Katarzyna Lewandowska and Martina {\v S}terclov{\'a} and Veronika M{\"u}ller and Marta H{\'a}jkov{\'a} and Kramer, {Mordechai R} and Jasna Tekavec-Trkanjec and Dragana Jovanovi{\'c} and Michael Studnicka and Natalia Stoeva and Klaus-Uwe Kirchg{\"a}ssler and Simona Littnerov{\'a} and Ladislav Du{\v s}ek and Va{\v s}{\'a}kov{\'a}, {Martina Koziar}",

note = "Studnicka: Paracelsus Medical University, SALK, Salzburg, Austria ",

year = "2022",

doi = "10.1371/journal.pone.0273854",

language = "English",

volume = "17",

pages = "e0273854",

journal = "PLOS ONE",

issn = "1932-6203",

publisher = "Public Library of Science ",

number = "9",

}

Májek, O, Gregor, J, Mogulkoć, N, Lewandowska, K, Šterclová, M, Müller, V, Hájková, M, Kramer, MR, Tekavec-Trkanjec, J, Jovanović, D, Studnicka, M, Stoeva, N, Kirchgässler, K-U, Littnerová, S, Dušek, L & Vašáková, MK 2022, 'Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.', PLOS ONE, vol. 17, no. 9, pp. e0273854. https://doi.org/10.1371/journal.pone.0273854

TY - JOUR

T1 - Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone.

AU - Májek, Ondřej

AU - Gregor, Jakub

AU - Mogulkoć, Nesrin

AU - Lewandowska, Katarzyna

AU - Šterclová, Martina

AU - Müller, Veronika

AU - Hájková, Marta

AU - Kramer, Mordechai R

AU - Tekavec-Trkanjec, Jasna

AU - Jovanović, Dragana

AU - Studnicka, Michael

AU - Stoeva, Natalia

AU - Kirchgässler, Klaus-Uwe

AU - Littnerová, Simona

AU - Dušek, Ladislav

AU - Vašáková, Martina Koziar

N1 - Studnicka: Paracelsus Medical University, SALK, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - NINTEDANIB

KW - CAPACITY

U2 - 10.1371/journal.pone.0273854

DO - 10.1371/journal.pone.0273854

M3 - Original Article (Journal)

C2 - 36048805

SN - 1932-6203

VL - 17

SP - e0273854

JO - PLOS ONE

JF - PLOS ONE

IS - 9

ER -